Michael J. Catelani
Net Worth

Last updated:

What is Michael J. Catelani net worth?

The estimated net worth of Mr. Michael J. Catelani is at least $2,467,581 as of 7 Jun 2024. He owns shares worth $107,041 as insider and has received compensation worth at least $2,360,540 in Anixa Biosciences, Inc..

What is the salary of Michael J. Catelani?

Mr. Michael J. Catelani salary is $337,220 per year as Chief Operating Officer, Chief Financial Officer & Corporation Sec. in Anixa Biosciences, Inc..

How old is Michael J. Catelani?

Mr. Michael J. Catelani is 58 years old, born in 1967.

What stocks does Michael J. Catelani currently own?

As insider, Mr. Michael J. Catelani owns shares in one company:

Company Title Shares Price per share Total value
Anixa Biosciences, Inc. (ANIX) Chief Operating Officer, Chief Financial Officer & Corporation Sec. 35,211 $3.04 $107,041

What does Anixa Biosciences, Inc. do?

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Michael J. Catelani insider trading

Anixa Biosciences, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 6,250 $2.4 $15,000
Purchase
Common Stock 5,500 $3.64 $20,020
Purchase
Common Stock 5,500 $2.66 $14,630
Purchase
Common Stock 2,509 $2.53 $6,348
Purchase
Common Stock 2,250 $4.45 $10,013

Anixa Biosciences key executives

Anixa Biosciences, Inc. executives and other stock owners filed with the SEC: